288 related articles for article (PubMed ID: 8962554)
1. Low density lipoprotein apheresis improves regional myocardial perfusion in patients with hypercholesterolemia and extensive coronary artery disease. LDL-Apheresis Atherosclerosis Regression Study (LAARS).
Aengevaeren WR; Kroon AA; Stalenhoef AF; Uijen GJ; van der Werf T
J Am Coll Cardiol; 1996 Dec; 28(7):1696-704. PubMed ID: 8962554
[TBL] [Abstract][Full Text] [Related]
2. Effect of apheresis of low-density lipoprotein on peripheral vascular disease in hypercholesterolemic patients with coronary artery disease.
Kroon AA; van Asten WN; Stalenhoef AF
Ann Intern Med; 1996 Dec; 125(12):945-54. PubMed ID: 8967704
[TBL] [Abstract][Full Text] [Related]
3. LDL-Apheresis Atherosclerosis Regression Study (LAARS). Effect of aggressive versus conventional lipid lowering treatment on coronary atherosclerosis.
Kroon AA; Aengevaeren WR; van der Werf T; Uijen GJ; Reiber JH; Bruschke AV; Stalenhoef AF
Circulation; 1996 May; 93(10):1826-35. PubMed ID: 8635262
[TBL] [Abstract][Full Text] [Related]
4. Familial Hypercholesterolaemia Regression Study: a randomised trial of low-density-lipoprotein apheresis.
Thompson GR; Maher VM; Matthews S; Kitano Y; Neuwirth C; Shortt MB; Davies G; Rees A; Mir A; Prescott RJ
Lancet; 1995 Apr; 345(8953):811-6. PubMed ID: 7898227
[TBL] [Abstract][Full Text] [Related]
5. Long-term efficacy of low-density lipoprotein apheresis on coronary heart disease in familial hypercholesterolemia. Hokuriku-FH-LDL-Apheresis Study Group.
Mabuchi H; Koizumi J; Shimizu M; Kajinami K; Miyamoto S; Ueda K; Takegoshi T
Am J Cardiol; 1998 Dec; 82(12):1489-95. PubMed ID: 9874053
[TBL] [Abstract][Full Text] [Related]
6. Long-term effect of low-density lipoprotein apheresis on plasma lipoproteins and coronary heart disease in native vessels and coronary bypass in severe heterozygous familial hypercholesterolemia.
Richter WO; Donner MG; Höfling B; Schwandt P
Metabolism; 1998 Jul; 47(7):863-8. PubMed ID: 9667236
[TBL] [Abstract][Full Text] [Related]
7. Effects of intensive lipid lowering by low-density lipoprotein apheresis on regression of coronary atherosclerosis in patients with familial hypercholesterolemia: Japan Low-density Lipoprotein Apheresis Coronary Atherosclerosis Prospective Study (L-CAPS).
Nishimura S; Sekiguchi M; Kano T; Ishiwata S; Nagasaki F; Nishide T; Okimoto T; Kutsumi Y; Kuwabara Y; Takatsu F; Nishikawa H; Daida H; Yamaguchi H
Atherosclerosis; 1999 Jun; 144(2):409-17. PubMed ID: 10407502
[TBL] [Abstract][Full Text] [Related]
8. Influence of atorvastatin versus simvastatin on fibrinogen and other hemorheological parameters in patients with severe hypercholesterolemia treated with regular low-density lipoprotein immunoadsorption apheresis.
Otto C; Geiss HC; Donner MG; Parhofer KG; Schwandt P
Ther Apher; 2000 Jun; 4(3):244-8. PubMed ID: 10910028
[TBL] [Abstract][Full Text] [Related]
9. A randomized, open-label, comparative study of simvastatin plus diet versus diet alone on angiographic retardation of coronary atherosclerosis in adult Japanese patients: Japanese utilization of simvastatin therapy (JUST) study.
Mizuno K; Nakamura H; Ohashi Y; Kaburagi T; Kitabatake A; Tochihara T; Hosoda S;
Clin Ther; 2004 Jun; 26(6):878-88. PubMed ID: 15262458
[TBL] [Abstract][Full Text] [Related]
10. Lipoprotein Apheresis Acutely Reverses Coronary Microvascular Dysfunction in Patients With Severe Hypercholesterolemia.
Wu MD; Moccetti F; Brown E; Davidson BP; Atkinson T; Belcik JT; Giraud G; Duell PB; Fazio S; Tavori H; Tsimikas S; Lindner JR
JACC Cardiovasc Imaging; 2019 Aug; 12(8 Pt 1):1430-1440. PubMed ID: 29909101
[TBL] [Abstract][Full Text] [Related]
11. Effect of HELP-LDL-apheresis on outcomes in patients with advanced coronary atherosclerosis and severe hypercholesterolemia.
Park JW; Merz M; Braun P
Atherosclerosis; 1998 Aug; 139(2):401-9. PubMed ID: 9712348
[TBL] [Abstract][Full Text] [Related]
12. Improved coronary vasodilatatory capacity by H.E.L.P. apheresis: comparing initial and chronic treatment.
Mellwig KP; van Buuren F; Schmidt HK; Wielepp P; Burchert W; Horstkotte D
Ther Apher Dial; 2006 Dec; 10(6):510-7. PubMed ID: 17199883
[TBL] [Abstract][Full Text] [Related]
13. Coronary atherosclerosis reduced in patients with familial hypercholesterolemia after intensive cholesterol lowering with low-density lipoprotein-apheresis: 1-year follow-up study. The Osaka LDL-Apheresis Multicenter Trial Group.
Kitabatake A; Sato H; Hori M; Kamada T; Kubori S; Hoki N; Minamino T; Yamada M; Kato T
Clin Ther; 1994; 16(3):416-28. PubMed ID: 7923308
[TBL] [Abstract][Full Text] [Related]
14. Long-term effect of low-density lipoprotein apheresis in a patient with heterozygous familial hypercholesterolemia: follow-up study using coronary angiography.
Saku K; Takeda Y; Jimi S; Okabe M; Shirai K; Nii T; Naito S; Arakawa K
J Cardiol; 1998 Apr; 31(4):239-45. PubMed ID: 9594373
[TBL] [Abstract][Full Text] [Related]
15. Functional evaluation of lipid-lowering therapy by pravastatin in the Regression Growth Evaluation Statin Study (REGRESS).
Aengevaeren WR; Uijen GJ; Jukema JW; Bruschke AV; van der Werf T
Circulation; 1997 Jul; 96(2):429-35. PubMed ID: 9244208
[TBL] [Abstract][Full Text] [Related]
16. Effects of low-density lipoprotein apheresis on coronary and carotid atherosclerosis and diabetic scleredema in patients with severe hypercholesterolemia.
Koga N
Ther Apher; 2001 Aug; 5(4):244-51. PubMed ID: 11724508
[TBL] [Abstract][Full Text] [Related]
17. Transition from LDL apheresis to evolocumab in heterozygous FH is equally effective in lowering LDL, without lowering HDL cholesterol.
Lappegård KT; Enebakk T; Thunhaug H; Hovland A
Atherosclerosis; 2016 Aug; 251():119-123. PubMed ID: 27318831
[TBL] [Abstract][Full Text] [Related]
18. The rebound of lipoproteins after LDL-apheresis. Kinetics and estimation of mean lipoprotein levels.
Kroon AA; van't Hof MA; Demacker PN; Stalenhoef AF
Atherosclerosis; 2000 Oct; 152(2):519-26. PubMed ID: 10998482
[TBL] [Abstract][Full Text] [Related]
19. The rebound of lipoproteins after LDL-apheresis. Effects on chemical composition and LDL-oxidizability.
Kroon AA; Demacker PN; Kleinveld HA; Stalenhoef AF
Atherosclerosis; 1999 Nov; 147(1):105-13. PubMed ID: 10525131
[TBL] [Abstract][Full Text] [Related]
20. [Maximal treatment of hypercholesteremia: what is possible?].
Thiery J
Arzneimittelforschung; 1990 Mar; 40(3A):383-8. PubMed ID: 2185771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
